Pulmonary and vascular pharmacology of sphingosine 1-phosphate.
about
FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosisTherapeutic decisions in multiple sclerosis: moving beyond efficacyMetabolomics analysis identifies different metabotypes of asthma severity.Why is effective treatment of asthma so difficult? An integrated systems biology hypothesis of asthmaMechanism of action of oral fingolimod (FTY720) in multiple sclerosis.Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis.Fingolimod and cardiac risk: latest findings and clinical implicationsEffect of fingolimod (FTY720) on cerebral blood flow, platelet function and macular thickness in healthy volunteers.Sphingosine-1-phosphate receptor 3 mediates sphingosine-1-phosphate induced release of weibel-palade bodies from endothelial cells.Functional variants of the sphingosine-1-phosphate receptor 1 gene associate with asthma susceptibilityTranscriptional modulation of SLC26A3 (DRA) by sphingosine-1-phosphate.FTY720 (fingolimod) for relapsing multiple sclerosis.Acute Anterior Uveitis in a Patient Taking Fingolimod (FTY720) for Multiple SclerosisPharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis.Oral drugs in multiple sclerosis therapy: an overview and a critical appraisal.Targeting sphingosine-1-phosphate signaling in lung diseases.The Ocular Manifestations of Drugs Used to Treat Multiple Sclerosis.Fingolimod-associated amenorrhea: a report of three cases.A sphingosine-1 phosphate agonist (FTY720) limits trauma/hemorrhagic shock-induced multiple organ dysfunction syndrome.A common cortactin gene variation confers differential susceptibility to severe asthmaSphingosine 1-phosphate (S1P) induces S1P2 receptor-dependent tonic contraction in murine iliac lymph vessels.Leucocyte scintigraphy with 111In-oxine for assessment of cell trafficking after extracorporeal photopheresis.Murine airway luminal antituberculosis memory CD8 T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment.
P2860
Q28288357-08D3A74D-0F40-4392-9C61-5B44B1C60C0DQ28541039-5CE373BB-5ADE-4079-912B-1D3AA2F03D31Q33587291-5351C568-60AF-450C-BC0E-AB678B81692EQ33773550-756248E6-3AB7-4DD3-8B03-E71303656CEFQ33810559-5C01B450-046A-4955-8C80-AF1B505DDB3AQ33881977-2991410A-EAC1-47CD-BB03-FA6A2A37162FQ33949504-07572F59-5E32-4CC2-AAD7-75471D344C23Q34635542-3BFA97B9-098F-4759-9E06-F2DF33CAC067Q35121901-76C17D9D-6E6E-43AF-A24F-30FBC0C1B022Q36390340-9BD92E36-E83B-4B5A-BEB6-32D5888BA7B2Q37071804-B20A7D70-2EF2-46E1-BF56-7E9A3EEC0591Q37154788-B992C896-69AD-4FBC-9598-EF967CADFBA6Q37562917-44E831A4-CA0B-4BEC-B127-96E00F4C07DEQ38192006-78FC5FF5-AC09-4C9B-BD02-76E247383A89Q38534132-E785816F-E67C-4C51-874B-A7D6A39F6F04Q38952840-0F430431-5FFB-4A30-963A-7F54922CBAA9Q39127843-D5DBCB02-F3CD-4639-A221-842136D02BA8Q39252582-937A52C0-E80E-45ED-9994-287389D5DA09Q41836874-A77757B4-0E5F-4F69-BEC0-F6EB2DDA91D6Q42622030-142CF83A-38D8-4064-BB35-91AB4F7290AFQ43826302-F8107B46-B5F7-4FB5-B9BD-93EE0020579CQ48787741-E38371EA-B2F9-4138-9F53-423298FE1696Q51888314-ECAB7E64-4606-48BB-A006-0D48C9514F48
P2860
Pulmonary and vascular pharmacology of sphingosine 1-phosphate.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Pulmonary and vascular pharmacology of sphingosine 1-phosphate.
@ast
Pulmonary and vascular pharmacology of sphingosine 1-phosphate.
@en
Pulmonary and vascular pharmacology of sphingosine 1-phosphate.
@nl
type
label
Pulmonary and vascular pharmacology of sphingosine 1-phosphate.
@ast
Pulmonary and vascular pharmacology of sphingosine 1-phosphate.
@en
Pulmonary and vascular pharmacology of sphingosine 1-phosphate.
@nl
prefLabel
Pulmonary and vascular pharmacology of sphingosine 1-phosphate.
@ast
Pulmonary and vascular pharmacology of sphingosine 1-phosphate.
@en
Pulmonary and vascular pharmacology of sphingosine 1-phosphate.
@nl
P1476
Pulmonary and vascular pharmacology of sphingosine 1-phosphate.
@en
P2093
Thomas Baumruker
Volker Brinkmann
P304
P356
10.1016/J.COPH.2005.12.004
P577
2006-03-23T00:00:00Z